Heart Failure

S. M. Hamza; N. Sharma; M. M. Sung; B. N. Zordoky; P. F. Kantor; J. R.B. Dyck

doi:10.1016/B978-0-12-386456-7.03304-9

Heart Failure

S. M. Hamza, N. Sharma, M. M. Sung, B. N. Zordoky, P. F. Kantor, J. R.B. Dyck

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

1 Scopus citations

Abstract

Cardiovascular disease is the leading cause of death and disabiLity in the world. By 2015, the World Health Organization predicts that cardiovascular disease will become the leading cause of death worldwide. While advancements in medical and surgical therapies have improved cardiac mortaLity, these advances have led to an increase in the incidence and prevalence of heart failure (HF). Indeed, 75% of cardiovascular patients with ischemic and hypertensive-heart disease will eventually develop HF, emphasizing the impact of this global epidemic. Symptomatic HF affects milLions of people worldwide and incurs bilLions of dollars in hospital costs annually, and the burden is expected to double in the next 1-2 decades. In addition, the current 1-year mortaLity rate after diagnosis of HF remains disturbingly high at 25-40%, and the condition has the worst effect on quaLity of Life of any chronic medical condition. This chapter will review the primary causes of adult HF and highLight causes of HF in the pediatric population.

Original language	English
Title of host publication	Pathobiology of Human Disease
Subtitle of host publication	A Dynamic Encyclopedia of Disease Mechanisms
Publisher	Elsevier Inc.
Pages	971-994
Number of pages	24
ISBN (Electronic)	9780123864567
ISBN (Print)	9780123864574
DOIs	https://doi.org/10.1016/B978-0-12-386456-7.03304-9
State	Published - Jan 1 2014

Keywords

Animal models
Biomarkers
Diabetic cardiomyopathy
Heart failure
Hypertensive-heart disease
Hypertrophic cardiomyopathy
Infiltrative cardiomyopathies
Ischemic cardiomyopathy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/B978-0-12-386456-7.03304-9

Cite this

@inbook{0df01e786f4a43b5814031bd35a86621,

title = "Heart Failure",

abstract = "Cardiovascular disease is the leading cause of death and disabiLity in the world. By 2015, the World Health Organization predicts that cardiovascular disease will become the leading cause of death worldwide. While advancements in medical and surgical therapies have improved cardiac mortaLity, these advances have led to an increase in the incidence and prevalence of heart failure (HF). Indeed, 75% of cardiovascular patients with ischemic and hypertensive-heart disease will eventually develop HF, emphasizing the impact of this global epidemic. Symptomatic HF affects milLions of people worldwide and incurs bilLions of dollars in hospital costs annually, and the burden is expected to double in the next 1-2 decades. In addition, the current 1-year mortaLity rate after diagnosis of HF remains disturbingly high at 25-40%, and the condition has the worst effect on quaLity of Life of any chronic medical condition. This chapter will review the primary causes of adult HF and highLight causes of HF in the pediatric population.",

keywords = "Animal models, Biomarkers, Diabetic cardiomyopathy, Heart failure, Hypertensive-heart disease, Hypertrophic cardiomyopathy, Infiltrative cardiomyopathies, Ischemic cardiomyopathy",

author = "Hamza, {S. M.} and N. Sharma and Sung, {M. M.} and Zordoky, {B. N.} and Kantor, {P. F.} and Dyck, {J. R.B.}",

year = "2014",

month = jan,

day = "1",

doi = "10.1016/B978-0-12-386456-7.03304-9",

language = "English",

isbn = "9780123864574",

pages = "971--994",

booktitle = "Pathobiology of Human Disease",

publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Heart Failure

AU - Hamza, S. M.

AU - Sharma, N.

AU - Sung, M. M.

AU - Zordoky, B. N.

AU - Kantor, P. F.

AU - Dyck, J. R.B.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Cardiovascular disease is the leading cause of death and disabiLity in the world. By 2015, the World Health Organization predicts that cardiovascular disease will become the leading cause of death worldwide. While advancements in medical and surgical therapies have improved cardiac mortaLity, these advances have led to an increase in the incidence and prevalence of heart failure (HF). Indeed, 75% of cardiovascular patients with ischemic and hypertensive-heart disease will eventually develop HF, emphasizing the impact of this global epidemic. Symptomatic HF affects milLions of people worldwide and incurs bilLions of dollars in hospital costs annually, and the burden is expected to double in the next 1-2 decades. In addition, the current 1-year mortaLity rate after diagnosis of HF remains disturbingly high at 25-40%, and the condition has the worst effect on quaLity of Life of any chronic medical condition. This chapter will review the primary causes of adult HF and highLight causes of HF in the pediatric population.

AB - Cardiovascular disease is the leading cause of death and disabiLity in the world. By 2015, the World Health Organization predicts that cardiovascular disease will become the leading cause of death worldwide. While advancements in medical and surgical therapies have improved cardiac mortaLity, these advances have led to an increase in the incidence and prevalence of heart failure (HF). Indeed, 75% of cardiovascular patients with ischemic and hypertensive-heart disease will eventually develop HF, emphasizing the impact of this global epidemic. Symptomatic HF affects milLions of people worldwide and incurs bilLions of dollars in hospital costs annually, and the burden is expected to double in the next 1-2 decades. In addition, the current 1-year mortaLity rate after diagnosis of HF remains disturbingly high at 25-40%, and the condition has the worst effect on quaLity of Life of any chronic medical condition. This chapter will review the primary causes of adult HF and highLight causes of HF in the pediatric population.

KW - Animal models

KW - Biomarkers

KW - Diabetic cardiomyopathy

KW - Heart failure

KW - Hypertensive-heart disease

KW - Hypertrophic cardiomyopathy

KW - Infiltrative cardiomyopathies

KW - Ischemic cardiomyopathy

UR - http://www.scopus.com/inward/record.url?scp=85043292163&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-386456-7.03304-9

DO - 10.1016/B978-0-12-386456-7.03304-9

M3 - Chapter

AN - SCOPUS:85043292163

SN - 9780123864574

SP - 971

EP - 994

BT - Pathobiology of Human Disease

PB - Elsevier Inc.

ER -

Heart Failure

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this